PGR, progesterone receptor, 5241

N. diseases: 392; N. variants: 33
Disease: Endometrial Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 Biomarker group BEFREE Adding dichotomous tumor ER or PR status to the panel of standard predictors did not improve both model discrimination and calibration.<b>Conclusions:</b> Obesity may be associated with greater endometrial tumor expression of ER and PR. 28052940 2017
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 Biomarker group CTD_human Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer. 23200943 2013
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 AlteredExpression group LHGDN Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes. 18386458 2008
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 AlteredExpression group LHGDN The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma. 18096667 2008
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 AlteredExpression group LHGDN Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma. 16999816 2006
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 AlteredExpression group LHGDN Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins. 15866121 2005
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 Biomarker group LHGDN Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines. 12517594 2003
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 AlteredExpression group LHGDN Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer. 14519645 2003
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 GeneticVariation group LHGDN A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. 12218173 2002
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.390 AlteredExpression group LHGDN Progesterone receptor mRNA variant containing novel exon insertions between exon 4 and exon 5 in human uterine endometrium. 12402980 2002